Loading stock data…
SLSN
$1.21+0.00 (+0.42%)
Market OpenUpdated 3:37 PM EDT
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Solesence, Inc. in the Consumer Defensive sector is trading at $1.21. The stock is currently near its 52-week low of $0.78, remaining 40.3% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$1.21
Potential Downside
0%
Whystock Fair Value$1.21
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and tita...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
5.56%
Volume
Today's trading volume
32,000
Recent News
Solesence (SLSN) Q4 2025 Earnings Transcript
Kevin Cureton: Thank you, operator, and thank you to our investors, brand partners and teammates who are joining us today. To walk you through how we wrapped up 2025, I'll turn the call over to our CFO, Laura Riffner. Laura Riffner: Thank you, Kevin.
SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs
Solesence incurs a Q1 loss per share as shipment delays pressure revenues, even as gross margin improves and the company reaffirms its 2026 profitability targets.
Solesence Inc (SLSN) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...
Solesence Inc (SLSN) reports a revenue dip but remains optimistic about future growth through new technologies and improved operational strategies.
Solesence, Inc. Common Stock Q1 2026 Earnings Call Summary
Moby summary of Solesence, Inc. Common Stock's Q1 2026 earnings call
Gross Margin Expansion Highlights Solésence’s Operational Restructuring Efforts (SLSN)
Solésence reported improved gross margin in the first quarter despite lower revenue and a return to a net loss, as the company continued executing its Transform & Transcend strategic initiative. Key Investor TakeawaysSolésence (NASDAQ:SLSN) posted first-quarter revenue of $13.